0001213900-26-015550
SEC filingPluri Inc. reported a net loss of $6.9 million for Q2 2026 (period ending December 31, 2025), with revenue of $198 thousand and a gross profit of $86 thousand. The company's operating loss was $6.5 million, driven primarily by research and development expenses of $3.8 million (net of $123 thousand in participation from government entities) and general and administrative expenses of $2.8 million. The balance sheet shows total assets of $30.6 million, with cash and cash equivalents of $4.7 million and short-term bank deposits of $7.8 million, but also significant liabilities including a $27.8 million loan from the European Investment Bank. Cash flow from operations was negative $8.7 million, partially offset by $6.5 million from investing activities (primarily withdrawal of short-term deposits) and $2.8 million from financing activities (including $2.5 million from issuance of common shares and warrants). The company reported a shareholders' deficit of $14.6 million and basic net loss per share of $1.00.
Pluri Inc. reported a net loss of $6.9 million for Q2 2026 (period ending December 31, 2025), compared to revenue of $198 thousand. The company generated gross profit of $86 thousand from cost of revenues of $112 thousand. Operating loss was $6.5 million, primarily driven by research and development expenses of $3.8 million (net of $123 thousand in participation from government entities) and general and administrative expenses of $2.8 million. Other financial expenses totaled $374 thousand, including interest expenses of $231 thousand. The company reported a tax benefit of $8 thousand. Net loss attributed to shareholders was $6.5 million, with basic and diluted net loss per share of $1.00 based on 9.3 million weighted average shares.
The company reported total revenue of $198 thousand for the quarter. No segment breakdown or geographic mix was provided in the filing. The cost of revenues was $112 thousand, resulting in gross profit of $86 thousand. No information about revenue growth drivers or product/service breakdown was disclosed in the available data.
The company's gross margin was 43.4% for the quarter, calculated from $86 thousand gross profit on $198 thousand revenue. Operating margin was negative 3282.8%, reflecting the significant operating loss relative to modest revenue. The cost structure shows research and development expenses of $3.8 million (net) and general and administrative expenses of $2.8 million, which together substantially exceeded gross profit. No prior period margin comparisons were provided in the available data.
Cash flow from operating activities was negative $8.7 million, primarily driven by the $6.9 million net loss adjusted for non-cash items including $2.1 million in share-based compensation and $259 thousand in depreciation and amortization. Investing activities provided $6.5 million, mainly from withdrawal of short-term deposits. Financing activities provided $2.8 million from SAFE proceeds and issuance of common shares and warrants. The balance sheet shows total assets of $30.6 million, including $4.7 million in cash and cash equivalents and $7.8 million in short-term bank deposits. Total current liabilities were $32.3 million, including a $27.8 million loan from the European Investment Bank. The company reported shareholders' deficit of $14.6 million and total deficit of $9.2 million.
No specific management guidance, strategic priorities, or forward-looking statements were provided in the available filing data. The company's financial position shows significant liabilities relative to assets, with a shareholders' deficit of $14.6 million. The company continues to invest heavily in research and development with $3.8 million in net R&D expenses for the quarter. No risk factors or specific outlook commentary was included in the provided data.